In Vitro Diagnostics (IVD) include reagents, instruments, and systems intended for use in the diagnosis of disease or other conditions, including the determination of the state of health, in order to treat or prevent disease. The reagents, instruments and systems are used in the collection, preparation, and examination of specimens taken from the human body. This includes Cardiac Disease, Hematological Disorders, Hormonal Disorders, Metabolic Disorder, Infectious Disease, IVD Analyzers, Oncology and Reproductive Health Diagnostics. Influenza Tests are laboratory based tests used to identify active or suspected influenza infections, using a combination of molecular diagnostics and immunoassay. GlobalData uses proprietary data and analytics to provide a comprehensive report on the influenza tests market in the UK. Buy the latest report here.
In 2023, GlobalData’s Market Model methodology determined that the leading player in the influenza tests market in the UK was bioMerieux followed by Danaher, Abbott Laboratories, Quidelortho, F. Hoffmann-La Roche, Becton Dickinson and Co, DiaSorin, Sekisui Diagnostics, Qiagen and Thermo Fisher Scientific.
Understanding market size can be crucial to evaluate opportunities and make informed decisions about market entry and exit. Medical device companies can identify attractive segments in respective markets as well as develop marketing strategies based on forecasts for those segments.
Influenza Tests include Influenza Antigen Tests, Influenza Multiplex NAATs, and Influenza Lowplex Nucleic Acid Amplification Tests (NAATs).
The influenza tests market in the UK can expand or contract due to a variety of reasons including population demographics, disease incidence and prevalence, macroeconomic issues, and geopolitical considerations. Disruption to a market could be caused by a sudden, unexpected change in these factors, but it could also be driven by changes in clinical practice, leading to a change in diagnosis or treatment of patients, as part of a process to generally improve medical practice.
For the latest analysis of the market size influenza tests in the UK, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.